Hospital-wide SARS-CoV-2 antibody screening of 4840 staff members in a University Medical Center in France: a cross-sectional study

ObjectivesHealthcare workers are more likely to be infected by SARS-CoV-2. In order to assess the infectious risk associated with working in a hospital, we sought to estimate the proportion of healthcare professionals infected with SARS-CoV-2 by screening staff in a University Medical Center in Fran...

Full description

Saved in:
Bibliographic Details
Published inBMJ open Vol. 12; no. 5; p. e047010
Main Authors Pierson-Marchandise, Marion, Castelain, Sandrine, Chevalier, Cassandra, Brochot, Etienne, Schmit, Jean-Luc, Diouf, Momar, Ganry, Olivier, Gignon, Maxime
Format Journal Article
LanguageEnglish
Published England British Medical Journal Publishing Group 11.05.2022
BMJ Publishing Group LTD
BMJ Publishing Group
SeriesOriginal research
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:ObjectivesHealthcare workers are more likely to be infected by SARS-CoV-2. In order to assess the infectious risk associated with working in a hospital, we sought to estimate the proportion of healthcare professionals infected with SARS-CoV-2 by screening staff in a University Medical Center in France.SettingA hospital-wide screening campaign (comprising a serological test and a questionnaire) ran from 18 May to 26 July 2020.Primary and secondary outcome measuresThe seroprevalence rate was analysed in a multivariate analysis according to sociodemographic variables (age, sex and profession), exposure to SARS-CoV-2 and symptoms.ResultsA total of 4840 professionals were included, corresponding to 74.5% of the centre’s staff. The seroprevalence rate (95% CI) was 9.7% (7.0% to 12.4%). Contact with a confirmed case of COVID-19 was significantly associated with seropositivity (OR (95% CI: 1.43, (1.15 to 1.78)). The seroprevalence rate was significantly higher among nursing assistants (17.6%) than among other healthcare professionals. The following symptoms were predictive of COVID-19: anosmia (OR (95% CI): 1.55, (1.49 to 1.62)), ageusia (1.21, (1.16 to 1.27)), fever (1.15, (1.12 to 1.18)), myalgia (1.03, (1.01 to 1.06)) and headache (1.03, (1.01 to 1.04)).
Bibliography:Original research
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMCID: PMC9096052
ISSN:2044-6055
2044-6055
DOI:10.1136/bmjopen-2020-047010